<DOC>
	<DOCNO>NCT01232543</DOCNO>
	<brief_summary>The aim trial assess Adrenal Suppression potential pediatric subject administer Product 0405 treatment Atopic Dermatitis</brief_summary>
	<brief_title>Safety Study Evaluating Adrenal Suppression Potential Product 0405 Pediatric Subjects With Atopic Dermatitis</brief_title>
	<detailed_description>Treatment medication administer topically , twice day 4 week .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Clinical diagnosis Atopic Dermatitis Good health exception Atopic Dermatitis Percent body surface area minimum requirement Subjects pregnant , nursing , plan pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>